サマリー

This report contains market size and forecasts of Tianeptine in China, including the following market information:
China Tianeptine Market Revenue, 2016-2021, 2022-2027, ($ millions)
China Tianeptine Market Sales, 2016-2021, 2022-2027, (K Units)
China top five Tianeptine companies in 2020 (%)
The global Tianeptine market size is expected to growth from US$ XX million in 2020 to US$ XX million by 2027; it is expected to grow at a CAGR of XX% during 2021-2027.
The China Tianeptine market was valued at US$ XX million in 2020 and is projected to reach US$ XX million by 2027, at a CAGR of XX% during the forecast period.
QYResearch has surveyed the Tianeptine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
China Tianeptine Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)
China Tianeptine Market Segment Percentages, By Type, 2020 (%)
Patent
Generic

China Tianeptine Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)
China Tianeptine Market Segment Percentages, By Application, 2020 (%)
Depression and Anxiety
Irritable Bowel Syndrome

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Tianeptine revenues in China market, 2016-2021 (Estimated), ($ millions)
Key companies Tianeptine revenues share in China market, 2020 (%)
Key companies Tianeptine sales in China market, 2016-2021 (Estimated), (K Units)
Key companies Tianeptine sales share in China market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Servier
Lupin Limited
PharmaS
Antibiotice
Serdia Pharmaceuticals
Alvogen
Bausch Health
Genefar B.V.
Arena Pharmaceuticals
Glenmark
Novartis
Dongwha Pharm
Liconsa SA
Mylan
Adamed
Neuraxpharm Arzneimittel
Grupo Insud

ページTOPに戻る

目次

1 Introduction to Research & Analysis Reports
1.1 Tianeptine Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Tianeptine Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year

2 China Tianeptine Overall Market Size
2.1 China Tianeptine Market Size: 2021 VS 2027
2.2 China Tianeptine Revenue, Prospects & Forecasts: 2016-2027
2.3 China Tianeptine Sales: 2016-2027

3 Company Landscape
3.1 Top Tianeptine Players in China Market
3.2 Top China Tianeptine Companies Ranked by Revenue
3.3 China Tianeptine Revenue by Companies
3.4 China Tianeptine Sales by Companies
3.5 China Tianeptine Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Tianeptine Companies in China Market, by Revenue in 2020
3.7 Manufacturers Tianeptine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Tianeptine Players in China Market
3.8.1 List of Tier 1 Tianeptine Companies in China
3.8.2 List of Tier 2 and Tier 3 Tianeptine Companies in China

4 Sights by Type
4.1 Overview
4.1.1 By Type - China Tianeptine Market Size Markets, 2021 & 2027
4.1.2 Patent
4.1.3 Generic
4.2 By Type - China Tianeptine Revenue & Forecasts
4.2.1 By Type - China Tianeptine Revenue, 2016-2021
4.2.2 By Type - China Tianeptine Revenue, 2022-2027
4.2.3 By Type - China Tianeptine Revenue Market Share, 2016-2027
4.3 By Type - China Tianeptine Sales & Forecasts
4.3.1 By Type - China Tianeptine Sales, 2016-2021
4.3.2 By Type - China Tianeptine Sales, 2022-2027
4.3.3 By Type - China Tianeptine Sales Market Share, 2016-2027
4.4 By Type - China Tianeptine Price (Manufacturers Selling Prices), 2016-2027

5 Sights by Application
5.1 Overview
5.1.1 By Application - China Tianeptine Market Size, 2021 & 2027
5.1.2 Depression and Anxiety
5.1.3 Irritable Bowel Syndrome
5.2 By Application - China Tianeptine Revenue & Forecasts
5.2.1 By Application - China Tianeptine Revenue, 2016-2021
5.2.2 By Application - China Tianeptine Revenue, 2022-2027
5.2.3 By Application - China Tianeptine Revenue Market Share, 2016-2027
5.3 By Application - China Tianeptine Sales & Forecasts
5.3.1 By Application - China Tianeptine Sales, 2016-2021
5.3.2 By Application - China Tianeptine Sales, 2022-2027
5.3.3 By Application - China Tianeptine Sales Market Share, 2016-2027
5.4 By Application - China Tianeptine Price (Manufacturers Selling Prices), 2016-2027

6 Manufacturers & Brands Profiles
6.1 Servier
6.1.1 Servier Corporation Information
6.1.2 Servier Overview
6.1.3 Servier Tianeptine Sales and Revenue in China Market (2016-2021)
6.1.4 Servier Tianeptine Product Description
6.1.5 Servier Recent Developments
6.2 Lupin Limited
6.2.1 Lupin Limited Corporation Information
6.2.2 Lupin Limited Overview
6.2.3 Lupin Limited Tianeptine Sales and Revenue in China Market (2016-2021)
6.2.4 Lupin Limited Tianeptine Product Description
6.2.5 Lupin Limited Recent Developments
6.3 PharmaS
6.3.1 PharmaS Corporation Information
6.3.2 PharmaS Overview
6.3.3 PharmaS Tianeptine Sales and Revenue in China Market (2016-2021)
6.3.4 PharmaS Tianeptine Product Description
6.3.5 PharmaS Recent Developments
6.4 Antibiotice
6.4.1 Antibiotice Corporation Information
6.4.2 Antibiotice Overview
6.4.3 Antibiotice Tianeptine Sales and Revenue in China Market (2016-2021)
6.4.4 Antibiotice Tianeptine Product Description
6.4.5 Antibiotice Recent Developments
6.5 Serdia Pharmaceuticals
6.5.1 Serdia Pharmaceuticals Corporation Information
6.5.2 Serdia Pharmaceuticals Overview
6.5.3 Serdia Pharmaceuticals Tianeptine Sales and Revenue in China Market (2016-2021)
6.5.4 Serdia Pharmaceuticals Tianeptine Product Description
6.5.5 Serdia Pharmaceuticals Recent Developments
6.6 Alvogen
6.6.1 Alvogen Corporation Information
6.6.2 Alvogen Overview
6.6.3 Alvogen Tianeptine Sales and Revenue in China Market (2016-2021)
6.6.4 Alvogen Tianeptine Product Description
6.6.5 Alvogen Recent Developments
6.7 Bausch Health
6.7.1 Bausch Health Corporation Information
6.7.2 Bausch Health Overview
6.7.3 Bausch Health Tianeptine Sales and Revenue in China Market (2016-2021)
6.7.4 Bausch Health Tianeptine Product Description
6.7.5 Bausch Health Recent Developments
6.8 Genefar B.V.
6.8.1 Genefar B.V. Corporation Information
6.8.2 Genefar B.V. Overview
6.8.3 Genefar B.V. Tianeptine Sales and Revenue in China Market (2016-2021)
6.8.4 Genefar B.V. Tianeptine Product Description
6.8.5 Genefar B.V. Recent Developments
6.9 Arena Pharmaceuticals
6.9.1 Arena Pharmaceuticals Corporation Information
6.9.2 Arena Pharmaceuticals Overview
6.9.3 Arena Pharmaceuticals Tianeptine Sales and Revenue in China Market (2016-2021)
6.9.4 Arena Pharmaceuticals Tianeptine Product Description
6.9.5 Arena Pharmaceuticals Recent Developments
6.10 Glenmark
6.10.1 Glenmark Corporation Information
6.10.2 Glenmark Overview
6.10.3 Glenmark Tianeptine Sales and Revenue in China Market (2016-2021)
6.10.4 Glenmark Tianeptine Product Description
6.10.5 Glenmark Recent Developments
6.11 Novartis
6.11.1 Novartis Corporation Information
6.11.2 Novartis Overview
6.11.3 Novartis Tianeptine Sales and Revenue in China Market (2016-2021)
6.11.4 Novartis Tianeptine Product Description
6.11.5 Novartis Recent Developments
6.12 Dongwha Pharm
6.12.1 Dongwha Pharm Corporation Information
6.12.2 Dongwha Pharm Overview
6.12.3 Dongwha Pharm Tianeptine Sales and Revenue in China Market (2016-2021)
6.12.4 Dongwha Pharm Tianeptine Product Description
6.12.5 Dongwha Pharm Recent Developments
6.13 Liconsa SA
6.13.1 Liconsa SA Corporation Information
6.13.2 Liconsa SA Overview
6.13.3 Liconsa SA Tianeptine Sales and Revenue in China Market (2016-2021)
6.13.4 Liconsa SA Tianeptine Product Description
6.13.5 Liconsa SA Recent Developments
6.14 Mylan
6.14.1 Mylan Corporation Information
6.14.2 Mylan Overview
6.14.3 Mylan Tianeptine Sales and Revenue in China Market (2016-2021)
6.14.4 Mylan Tianeptine Product Description
6.14.5 Mylan Recent Developments
6.15 Adamed
6.15.1 Adamed Corporation Information
6.15.2 Adamed Overview
6.15.3 Adamed Tianeptine Sales and Revenue in China Market (2016-2021)
6.15.4 Adamed Tianeptine Product Description
6.15.5 Adamed Recent Developments
6.16 Neuraxpharm Arzneimittel
6.16.1 Neuraxpharm Arzneimittel Corporation Information
6.16.2 Neuraxpharm Arzneimittel Overview
6.16.3 Neuraxpharm Arzneimittel Tianeptine Sales and Revenue in China Market (2016-2021)
6.16.4 Neuraxpharm Arzneimittel Tianeptine Product Description
6.16.5 Neuraxpharm Arzneimittel Recent Developments
6.17 Grupo Insud
6.17.1 Grupo Insud Corporation Information
6.17.2 Grupo Insud Overview
6.17.3 Grupo Insud Tianeptine Sales and Revenue in China Market (2016-2021)
6.17.4 Grupo Insud Tianeptine Product Description
6.17.5 Grupo Insud Recent Developments

7 China Tianeptine Production Capacity, Analysis
7.1 China Tianeptine Production Capacity, 2016-2027
7.2 Tianeptine Production Capacity of Key Manufacturers in China Market

8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints

9 Tianeptine Supply Chain Analysis
9.1 Tianeptine Industry Value Chain
9.2 Tianeptine Upstream Market
9.3 Tianeptine Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Tianeptine Distributors and Sales Agents in China Market

10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer